A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 When Administered Inhaled Via a New Dry Powder Inhaler and Via Turbuhaler.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2012
At a glance
- Drugs AZD 8683 (Primary) ; AZD 8683 (Primary) ; AZD 8683 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 18 Dec 2012 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 03 Dec 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 22 Aug 2012 New trial record